• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY (BD) PAXGENE® BLOOD RNA TUBE; RNA PREANALYTICAL SYSTEMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY (BD) PAXGENE® BLOOD RNA TUBE; RNA PREANALYTICAL SYSTEMS Back to Search Results
Model Number 762165
Device Problem Device Ingredient or Reagent Problem (2910)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/08/2023
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that after centrifugation with paxgene® blood rna tube the rna pellets were not able to resuspend, it was a "tar" like substance that would not be dissolved by water.There was no report of patient impact.The following information was provided by the initial reporter: we recently used the paxgene rna stabilizing tubes for blood collection and i had an issue when collecting the crude rna that wasn¿t covered for any troubleshooting guides.First, the crude rna pellets that were collected after the first centrifugation were not able to be fully resuspended.There was almost like a tar substance that would not be dissolved by water.I would vortex for minutes at a time without any progress on dissolving the pellet.Additionally, after the proteinase treatment and 16,000 x g centrifugation, there were some samples that did not pellet the debris.The debris was a mass of slime and so i could not retrieve the 180l back out of my rna sample.I tried to perform the centrifugation again, but it did fully resolve the issue.
 
Event Description
It was reported that after centrifugation with paxgene® blood rna tube the rna pellets were not able to resuspend, it was a "tar" like substance that would not be dissolved by water.There was no report of patient impact.The following information was provided by the initial reporter: we recently used the paxgene rna stabilizing tubes for blood collection and i had an issue when collecting the crude rna that wasn't covered for any troubleshooting guides.First, the crude rna pellets that were collected after the first centrifugation were not able to be fully resuspended.There was almost like a tar substance that would not be dissolved by water.I would vortex for minutes at a time without any progress on dissolving the pellet.Additionally, after the proteinase treatment and 16,000 x g centrifugation, there were some samples that did not pellet the debris.The debris was a mass of slime and so i could not retrieve the 180 ¿l back out of my rna sample.I tried to perform the centrifugation again, but it did fully resolve the issue.
 
Manufacturer Narrative
H.6.Investigation summary: bd had not received samples or photos for investigation.Therefore, 100 retention samples from bd inventory were visually inspected with no issues identified.Based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.There were no related quality issues during manufacturing of the product.The bd ifu (instructions for use) does not provide for any specific yield claims.Yields depend on the patient, the quality of the specimen, and the method used for isolation.A review of the ifu is recommended.This complaint is unable to be confirmed for low yield.Bd was not able to identify a root cause for the indicated failure mode.Complaints received for this device and reported condition will continue to be tracked and trended.Our business team regularly reviews the collected data for identification of emerging trends.A bd expert for paxgene was provided customer information so he and qiagen team can review process with customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PAXGENE® BLOOD RNA TUBE
Type of Device
RNA PREANALYTICAL SYSTEMS
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY (BD)
belliver way
belliver industrial estate
plymouth
UK 
Manufacturer (Section G)
BECTON, DICKINSON AND COMPANY (BD)
belliver way
belliver industrial estate
plymouth
UK  
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8448235433
MDR Report Key16640987
MDR Text Key312358520
Report Number9617032-2023-00316
Device Sequence Number1
Product Code NTW
UDI-Device Identifier54053727621653
UDI-Public(01)54053727621653
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K082150
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/29/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date08/31/2023
Device Model Number762165
Device Catalogue Number762165
Device Lot Number1270374
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/19/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/27/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-